Phase IB trial of ACY-1215 (Ricolinostat) combined with nab-paclitaxel in metastatic breast cancer.

被引：0
|
作者：
Kalinsky, Kevin
Onishi, Maika
Yu, JiYang
Trivedi, Meghna S.
Accordino, Melissa Kate
Crew, Katherine D.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.1058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1058
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase 2 trial of the IDO pathway inhibitor indoximod plus gemcitabine / nab-paclitaxel for the treatment of patients with metastatic pancreas cancer.
    Bahary, Nathan
    Wang-Gillam, Andrea
    Haraldsdottir, Sigurdis
    Somer, Bradley G.
    Lee, Jin S.
    O'Rourke, Mark Allen
    Nayak-Kapoor, Asha
    Beatty, Gregory Lawrence
    Liu, Mingen
    Delman, Devora
    Rossi, Gabriela R.
    Kennedy, Eugene Paul
    Vahanian, Nicholas N.
    Link, Charles J.
    Garrido-Laguna, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] Phase I trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer.
    Mahipal, Amit
    Springett, Gregory M.
    Burke, Nancy
    Bertels, Barbara
    Wapinsky, Georgine
    Almhanna, Khaldoun
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [33] Cost-effectiveness of combined atezolizumab/nab-paclitaxel for advanced triple-negative breast cancer.
    Salans, Mia A.
    Cherry, Daniel R.
    Yip, Anthony T.
    Courtney, Patrick T.
    Kumar, Abhishek
    Murphy, James Don
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas
    Hidalgo, Manuel
    Garcia-Carbonero, Rocio
    Lim, Kian-Huat
    Messersmith, Wells A.
    Garrido-Laguna, Ignacio
    Borazanci, Erkut
    Lowy, Andrew M.
    Rodriguez, Laura Medina
    Laheru, Daniel
    Salvador-Barbero, Beatriz
    Malumbres, Marcos
    Shields, David J.
    Grossman, Joseph E.
    Huang, Xin
    Tammaro, Meggan
    Martini, Jean-Francois
    Yu, Yanke
    Kern, Kenneth
    Macarulla, Teresa
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (11): : 1326 - 1333
  • [35] Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma
    Grierson, Patrick M.
    Tan, Benjamin
    Pedersen, Katrina S.
    Park, Haeseong
    Suresh, Rama
    Amin, Manik A.
    Trikalinos, Nikolaos A.
    Knoerzer, Deborah
    Kreider, Brent
    Reddy, Anupama
    Liu, Jingxia
    Der, Channing J.
    Wang-Gillam, Andrea
    Lim, Kian-Huat
    ONCOLOGIST, 2023, 28 (02): : E115 - E123
  • [36] A phase I/II study of antroquinonol in combination with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer.
    Shan, Yan-Shen
    Li, Chung-Pin
    Khan, Gazala
    Lee, Woo Jin
    Choi, Hye Jin
    Chang, Heung-Moon
    Lee, Moon Hee
    Wallmark, John M.
    Chen, Pei-Ni
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 648 - 648
  • [37] Correction to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
    Glen J. Weiss
    Lisa Blaydorn
    Julia Beck
    Kirsten Bornemann-Kolatzki
    Howard Urnovitz
    Ekkhard Schütz
    Vivek Khemka
    Investigational New Drugs, 2019, 37 : 797 - 797
  • [38] A phase Ib extension study of cancer sternness inhibitor BB608 (napabucasin) in combination with gemcitabine and nab-paclitaxel (nab-PTX) in patients (pts) with metastatic pancreatic cancer.
    El-Rayes, Bassel F.
    Shanda, Safi
    Starodub, Alexander
    O'Neil, Bert H.
    Hanna, Wahid Tewfik
    Shaib, Walid Labib
    Oh, Cindy
    Li, Wei
    Li, Youzhi
    Borodyansky, Laura
    Li, Chiang
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Neoadjuvant nab-paclitaxel in breast cancer: trial results and patient care
    Colleoni, Marco
    LANCET ONCOLOGY, 2016, 17 (03): : 265 - 266
  • [40] nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer
    Megerdichian, Christine
    Olimpiadi, Yuliya
    Hurvitz, Sara A.
    CANCER TREATMENT REVIEWS, 2014, 40 (05) : 614 - 625
12345